[Cardiac resynchronization therapy]

Azusa Furugen1, Naoki Matsuda, Hiroshi Kasanuki

  • 1Department of Cardiology, Tokyo Women's Medical University.

Insights

Cardiac resynchronization therapy (CRT) improves heart failure outcomes, but not all patients respond. Echocardiography assessment of mechanical dyssynchrony may better select patients for CRT than QRS duration.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Imaging

Context:

  • Chronic heart failure (CHF) patients often have intraventricular conduction delay, leading to ventricular mechanical dyssynchrony.
  • Ventricular mechanical dyssynchrony exacerbates systolic dysfunction in CHF.
  • Cardiac resynchronization therapy (CRT) via biventricular pacing offers significant clinical benefits for CHF patients.

Purpose:

  • To evaluate the effectiveness of echocardiography in assessing mechanical dyssynchrony for patient selection in CRT.
  • To compare echocardiography-based dyssynchrony assessment with QRS duration for predicting CRT response.

Summary:

  • Intraventricular conduction delay affects one-third of CHF patients, worsening systolic function.
  • While CRT improves symptoms, exercise tolerance, hemodynamics, hospitalization rates, and mortality, approximately 30% of patients do not respond.
  • Direct echocardiographic assessment of mechanical dyssynchrony appears more critical than QRS duration for identifying suitable CRT candidates.

Impact:

  • Optimizing patient selection for CRT can improve therapeutic efficacy and reduce healthcare costs.
  • This approach may lead to better clinical outcomes for heart failure patients undergoing CRT.
  • Highlights the importance of advanced imaging techniques in personalized cardiac device therapy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.